INTRODUCTION
The hydrolysis of the 28-amino-acid-residue human atrial natriuretic peptide (a-hANP) by porcine renal microvillar membranes is predominantly the result of an initial attack by endopeptidase-24.11 (Stephenson & Kenny, 1987b) . The first bond to be hydrolysed by the purified enzyme is Cys7-Phe8, thus opening the 17-residue ring and generating an inactive product, designated a-hANP', which is eluted on h.p.l.c. with a shorter retention time than the intact peptide [for a review see Kenny & Stephenson (1988) ]. This pattern of attack is common to both renal microvillar membranes and the purified endopeptidase and is inhibitable by phosphoramidon. Prolonged incubation with endopeptidase-24.11 further degrades cx-hANP' to smaller fragments, resulting from the hydrolysis at seven sites (Stephenson & Kenny, 1987b; Vanneste et al., 1988) .
Recently a peptide with pharmacological actions similar to those of a-hANP has been isolated from porcine brain and named 'brain natriuretic peptide ' (BNP; Sudoh et al., 1988a) .
The first form of BNP to be isolated was a 26-amino-acid-residue peptide (BNP-26) with considerable sequence similarity to ahANP (Fig. 1 ). Another form, with an additional six residues at the N-terminus, BNP-32, is also present in brain (Sudoh et al., 1988b ) and a larger precursor form, of 12 kDa, has been found in pig heart . In pig brain BNP is present in 13-fold higher concentration than ANP . However, there appears to be some species variation, since radioimmunoassays have detected BNP in pig and dog brains but not in human, monkey or rat brain (Itoh et al., 1989; Aburaya et al., 1989b) . Others, however, have been able to map BNP by immunohistochemistry in rat brain (Saper et al., 1989) .
In peripheral tissues there are numerous reports of the presence of BNP peptides in cardiac atria, and cDNA clones encoding BNP precursors have been prepared from libraries of atrial tissue from several species (e.g. Aburaya et al., 1989a; Kojima et al., 1989; Seilhamer et al., 1989) . The peripheral actions of BNP and ANP are very similar (Hashiguchi et al., 1988; Hirata et al., 1988; Song et al., 1988) . When BNP was given by the intracerebroventricular route it had no effect on basal bloodpressure readings, but inhibited the pressor response of angiotensin II (Shirakami et al., 1988) . Although binding sites in tissues seem to be shared by both ANP and BNP (Oehlenschlager et al., 1989) , a receptor which preferentially binds BNP and is linked to a guanylate cyclase has recently been cloned from a human placental library (Chang et al., 1989) .
Little is known about the metabolism of BNP, but it has been shown to be degraded by dog kidney cortical membranes, and this hydrolysis was inhibited by phosphoramidon, showing endopeptidase-24.11 to be the enzyme initiating the attack (VogtSchaden et al., 1989) . Those authors also defined the points of hydrolysis by the membrane preparation as: Arg8-Leu9, Ser 4-Leu15, Leul5-Ser'6, Ser 6-Gly'7 and Gly'7-Leu8, the second being the principal point of attack generating a ringopened product. Hydrolysis at Cys4-Phe5, the initial attack on ahANP, was not observed.
We have recently completed a biochemical and immunohistochemical survey of membrane peptidases in the choroid plexus (Bourne et al., 1989) . Most of the renal microvillar peptidases are present in porcine choroid plexus membrane preparations (only carboxypeptidase P, aminopeptidase P and membrane dipeptidase being undetected), but, with the exception of carboxypeptidase M, at much lower levels of activity. Endopeptidase-24.11 is uniquely located on the luminal surface of the choroid plexus epithelial cells, while aminopeptidase N and peptidyl dipeptidase A ('angiotensin-converting enzyme') have a dual location on epithelial and endothelial membranes. All three are also found on pial membranes, so that the Vol. 271 Abbreviations used: ANP, atrial natriuretic peptide; a-hANP, a-(human) atrial natriuretic peptide; BNP, brain natriuretic peptide (BNP-26, the porcine 26-residue peptide); iPr2P-F, di-isopropyl fluorophosphate.
* To whom correspondence and reprint requests should be sent.
cerebrospinal fluid is enclosed by peptidase-rich membrane surfaces. Receptors for a-ANP are present in the choroid plexus (Bianchi et al., 1986; Lynch et al., 1986; McCarty & Plunkett, 1986) , and intercerebroventricular injection of a-ANP decreases the production of cerebrospinal fluid by the cells of the choroid plexus (Steardo & Nathanson, 1987) .
To date there has been only one report on the degradation of a-hANP by human choroid plexus membranes (DeschodtLanckman et al., 1988) . In that report the C-terminal tyrosine residue was iodinated and attention was focused on the hydrolysis of the -Ser25-Phe26-bond, which liberates the C-terminal fragment Phe-Arg-Tyr. Unlike kidney microvillar membranes, where this product is the result of endopeptidase-24.11 action (Stephenson & Kenny, 1987b) , these authors found that in their crude choroid plexus membrane fraction only some 25 % of this product was attributable to the action of endopeptidase-24.11, the rest being due to other metallo-and cysteine-endopeptidases.
In the present study we have reinvestigated the metabolism of a-hANP by the choroid plexus membranes previously characterized in this laboratory (Bourne et al., 1989) and have compared this with the metabolism of porcine BNP-26 by membrane preparations and purified peptidases. We have found that endopeptidase-24. 11 is the main enzyme responsible for the hydrolysis of both natriuretic factors.
EXPERIMENTAL Enzymes, peptides and inhibitors
Endopeptidase-24. 11 and peptidyl dipeptidase A were purified from pig kidney membranes (Gee et al., 1983; Bull et al., 1985) . a-hANP was purchased from the Sigma Chemical Co., and BNP-26 was bought from the Peptide Institute (Scientific MarketingAssociates, LondonNl 4RH, U.K.). Phosphoramidon was obtained from Protein Research Foundation, Osaka, Japan; amastatin and iPr2P-F were from Sigma Chemical Co., and captopril was a gift from the Squibb Institute forn Medical Research, Princeton, NJ, U.S.A.
Membrane preparations
These were prepared from pig, as previously described: renal microvillar membranes (Booth & Kenny, 1974) and choroid plexus membranes (Bourne et al., 1989) . For the choroid plexus membranes (pellet 2a) an additional washing step using mannitol/Tris homogenization buffer containing 250 mM-NaCl was introduced before resuspension.
Incubations with membranes and peptidases
The conditions were those described previously (Stephenson & Kenny, 1987a,b) . For choroid plexus membranes the incubation mixture (volume 100 ,l) contained 15 ,ug of protein. Collection and analysis of peptide products by h.p.l.c.
This and all other methods were as described by Stephenson & Kenny (1987a,b) 
Products of hydrolysis of oc-hANP incubation with choroid plexus
A study of the time course showed that some product peaks resolved by h.p.l.c. were transient (results not shown), but incubation for 25 min permitted adequate quantification of the main initial product peak (peak 4, Fig. 2a ). In the presence of 1 #uM-phosphoramidon (Fig. 2b ) the area of this peak was reduced to 16%, whereas 10 ,tM-amastatin and 1 uM-captopril had no effect (results not shown). The areas of peaks 1, 2 and 3 were small, being less than 5 % of that of peak 4, and were not accurately quantified, but they, too, appeared to be suppressed in the presence of phosphoramidon. The residual phosphoramidoninsensitive activity generating peak 4 was abolished by 1 mmdithiothreitol, probably by its chelating action. The retention time of peak 4 is identical with that designated a-hANP' (under the same conditions of elution) by Stephenson & Kenny (1987b) as the product of the initial cleavage by kidney microvillar membranes or purified endopeptidase-24. 11. This product was later shown to be the result of hydrolysis at the Cys7-Phe8 bond (Kenny & Stephenson, 1988) . The amino acid analysis of the peptide in peak 4 corresponded to that of a-hANP' and was therefore consistent with a ring-opening attack and may be identified as at the same bond.
Of the minor products after 25 min incubation, peak 2 was identified with the C-terminal fragment Phe-Arg-Tyr by coelution with a synthetic marker peptide (Stephenson & Kenny, 1987b) . In an extended incubation (120 min) the presence of 20,M-amastatin enhanced peak 2 (Fig. 2c) under conditions where virtually no substrate remained. In a parallel incubation in the presence of phosphoramidon (Fig. 2d) , no peak corresponding to Phe-Arg-Tyr was detected, but peak 4 (a-hANP'), attributable to the action of the phosphoramidon-insensitive enzyme(s), was enhanced compared with the 25-min incubations, 27 % of the substrate being converted into a.-hANP'.
Hydrolysis of BNP by choroid plexus, kidney membranes and by endopeptidase-24.11 Fig. 3 compares the h.p.l.c. elution profiles produced by the hydrolysis of BNP by choroid plexus, kidney microvillar membranes and purified endopeptidase-24. 11, the conditions being selected to produce similar degrees of degradation of BNP. The three patterns are very similar. Seven product peaks can be discerned, of which peak 5 was shown to be the main initial product from a time course with choroid plexus membranes (results not shown). This product underwent further degradation on longer incubation, a process which was delayed about 30 min, (a) (b) but not slowed, by 100,uM-amastatin. The similarity of pattern produced by the two types of membranes and by endopeptidase-24.11 is consistent with this enzyme being the principal peptidase in the attack. This point was supported, in a similar incubation with choroid plexus membranes, by the effects of inhibitors on the yields of the products (Table 1 ). In the presence of phosphoramidon, only 6% breakdown of BNP was observed, and the main product (peak 5) was decreased to 2 % ofthe uninhibited control; the other relatively small peaks were 0-10% of the uninhibited value. Amastatin had an effect in increasing the yield of peak I and preventing the generation of peak 3, but both these peaks represented minor products. Captopril had no effect except that peak 4 was slightly enhanced. The ability of purified peptidyl dipeptidase A to hydrolyse BNP was investigated in a separate experiment in which 5 nmol of BNP was incubated with 100 ng of enzyme in the presence of I /SM-phosphoramidon, 100 /SMamastatin and 100,4uM-iPr2P-F for 24 h at 37 'C. No decrease in the area of the BNP peak was observed and no product peaks were generated.
Bonds of BNP hydrolysed during incubation with endopeptidase-24.11
In a further experiment, BNP was incubated with purified The peaks from the four h.p.l.c. runs have been assigned Roman numerals to distinguish them from those in Table 1 , because the elution system here contained trifluoroacetic in place of phosphoric acid. Note that peak I corresponds to peak 5 (being BNP'; the initial product of hydrolysis at Ser4-Leu15), peak II corresponds to peak 4, and peak III corresponds to peak 2. For the 48 h incubation the inhibitors, 10 /uM-amastatin and 100 1#M-iPr2P-F were included. In this experiment all the incubation mixtures (volume 100 u1) contained 70 ng of purified endopeptidase-24.11 and 50,uM-BNP (i.e. 5 nmol). The yields were calculated from the sequences as previously described (Stephenson & Kenny, 1987a See the Experimental section and Table 2 for details. Lines indicate peptide fragments.
endopeptidase-24. 11 for periods from 0.7 to 48 h ( Table 2 ). The products were resolved by h.p.l.c and the main peaks collected for identification by sequencing. The initial product was the result of hydrolysis at Ser'4-Leu'5, this peak (referred to as I in Table 2 ) being identical with peak 5 in Table 1 and Fig. 3 , in which experiments the elution system was slightly different. This product, which involves the opening of the ring, may, by analogy to ac-hANP', be called BNP'. BNP' was short-lived, being undetected at 6 h. Other transient products were those defined as peaks II and III, which involved cleavage at Ile2-Gly'3, Arg8-Leu9 and Gly'7-Leu'8. The other products, peaks IV-VIII, either reached a plateau or increased throughout the incubation, there being stoichiometric yields (5 nmol) of products IV and VI. It may be noted that the inclusion ofinhibitors ofaminopeptidases and serine peptidases in the 48 h incubation had no effect on the products. The pattern of attack is summarized in Fig. 4 . The bonds observed to be cleaved in these incubations were Ser14-Leu'5, Ile'2-Gly'3, Arg8-Leu9, Glyl7-Leu'8, Val22-Leu23, Arg'1-Ile'2 and Cys4-Phe5. Some predicted fragments, Gly'3-Ser14 and Leu9-Asp10-Arg11-Ile 2, were not seen in the elution profile.
DISCUSSION
Hydrolysis of at-hANP by choroid plexus Although membrane peptidases are considerably less abundant in the choroid plexus membrane preparation compared with that from kidney microvilli (a difference for which compensation was made by increasing the membrane protein 7.5-fold in the incubation), the mode of attack was similar. The initial product, a-hANP', resulted from the hydrolysis of the Cys7-Phe8 bond mainly by the action of endopeptidase-24. 11. However, at 25 min 16 % of a-hANP' was formed by a phosphoramidon-insensitive metallo-endopeptidase, and this activity was more significant at 120 min. The identity of the enzyme(s) responsible is not clear, but may relate to the phosphoramidon-insensitive activity seen with kidney microvillar membranes (Stephenson & Kenny, 1987b) . However, the release of the C-terminal tripeptide by human choroid plexus membranes was reported by DeschodtLanckman et al. (1988) to be mainly the result of peptidase activity insensitive to phosphoramidon, whereas our study attributes nearly all of this cleavage to endopeptidase-24. 11. The most probable explanation for this discrepancy lies in differences in the membrane preparations. In our experiments the preparation was a pellet, obtained after Mg2" treatment, which had been subject to a washing step in 0.25 M-NaCl; in the other case it was a 15 000 g/20 min crude membrane preparation that had not been washed free of cytosolic enzymes. However, it is also to be noted that we studied the degradation of 50 ,M-ox-hANP, whereas Deschodt-Lanckman et al. (1988) used a l25l-labelled peptide at 30 pM.
Hydrolysis of BNP by choroid plexus membranes When the two sequences are aligned ( Fig. 1) with the halfcystine residues, there are 16 identical amino acids and several conservative substitutions. One might expect that the mode of attack by renal membranes would be similar for the two peptides. However, as reported by Vogt-Schaden et al. (1989) , the Ser14-Leu'5 bond, rather than the Cys-Phe bond, was the preferred initial point of hydrolysis. Using a pure preparation of pig kidney endopeptidase-24. 11 we have monitored the stepwise degradation of BNP and have confirmed that this bond is the first to be attacked. The subsequent steps involve the shortening of both portions of the opened ring by the removal of small fragments from the exposed ends. In this process each of the bonds cleaved conformed to the rule that the P1' residue should be hydrophobic (see, e.g., Matsas et al., 1984) , with one exception, Ile-Gly, which was the second point of attack. The others generated Leu-or Phe-N-terminal fragments, the latter arising from the hydrolysis of the Cys4-Phe5 bond. This was detected at 6 h and persisted throughout the 48 h incubation. Compared with the earlier report on BNP metabolism by dog renal membranes (Vogt-Schaden et al., 1989) , we failed to observe the hydrolysis at Leul5-Ser 16 or Ser6-Gly'7, but did find hydrolysis at Cys5-Phe4 and Ile 2-Gly 3, which they did not observe. We confirm hydrolyses at Arg8-Leu9, Ser14-Leul5 and Glyl7-Leu18. These differences probably relate to their use ofa crude membrane preparation, rather than a highly purified enzyme, as well as to the longer incubations used here to reveal all major sites of attack.
The h.p.l.c. profiles of BNP hydrolysis after short incubations with either choroid plexus membranes, renal microvillar membranes or purified endopeptidase-24. 11 were identical. This, and the profound inhibitory effect of phosphoramidon, demonstrates that, in both types of membrane, endopeptidase-24.11 initiates the attack.
